Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Drug company (FDA labeler)

Linde Gas & Equipment Inc.

NDC labeler code: 59579

What is a labeler?

The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.

Official FDA data only

Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.

Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.

At a glance

8Products (NDC)

Prescription medicines

FDA applications for these products

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
  • ANDA: Abbreviated New Drug Application: how a generic version is approved.
ApprovedApplicationMedicineSponsor
October 2, 2018ANDA207141 Nitric oxide
NOXIVENT
Vero Biotech Inc
January 9, 2017NDA209989 Nitrous oxide
NITROUS OXIDE, USP
Matheson Tri-Gas Inc
August 5, 2013NDA205910 Air
MEDICAL AIR, USP
Praxair Distribution Mid-Atlantic LLC
August 5, 2013NDA205912 Helium
HELIUM, USP
Praxair Distribution Inc
July 21, 2013NDA205849 Carbon dioxide-oxygen-nitrogen mixture, Oxygen
OXYGEN, USP
Praxair Inc
July 21, 2013NDA205850 Nitrogen
NITROGEN, NF
Praxair Inc
July 21, 2013NDA205852 Carbon dioxide
CARBON DIOXIDE, USP
Praxair Inc

The sponsor is the company that holds the FDA application; it can differ from the labeler.

Recall timeline

2015

  1. September 16, 2015 · Class III · Terminated · D-0782-2016 · Air

    CGMP Deviations: Confirmed customer compliant of odor when turning on a cylinder of medical air.

    UN1002 Air, Compressed, Breathing Grade, USP, Distributed by Praxair Distribution, Inc. Roseville, MN 55113, NDC 59579-006.

What do the recall classes mean?

Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
  3. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 10, 2026, retrieved November 14, 2026

FDA Enforcement Report search → · Report an error →